BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Herpes Cure Advocacy - ECPv6.16.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Herpes Cure Advocacy
X-ORIGINAL-URL:https://herpescureadvocacy.com
X-WR-CALDESC:Events for Herpes Cure Advocacy
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251007T150000
DTEND;TZID=America/New_York:20251007T160000
DTSTAMP:20250916T143940Z
CREATED:20250812T144751Z
LAST-MODIFIED:20250916T143940Z
UID:6260-1759849200-1759852800@herpescureadvocacy.com
SUMMARY:Therapy and prevention of long-term cognitive impairment following neonatal herpes simplex virus infections
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/therapy-and-prevention-of-long-term-cognitive-impairment-following-neonatal-herpes-simplex-virus-infections/
ATTACH;FMTTYPE=image/jpeg:https://herpescureadvocacy.com/wp-content/uploads/2024/11/leib-web-e1732391062942.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251013T160000
DTEND;TZID=America/New_York:20251013T170000
DTSTAMP:20250919T050226Z
CREATED:20250521T013259Z
LAST-MODIFIED:20250919T050226Z
UID:5945-1760371200-1760374800@herpescureadvocacy.com
SUMMARY:Development of Better Serological Tests for HSV-1 and HSV-2 Infections with David Camerini
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/development-of-better-serological-tests-for-hsv-1-and-hsv-2-infections-with-david-camerini/
CATEGORIES:Guest Speaker
END:VEVENT
END:VCALENDAR